Episode 168
Peter Hotez, MD, PhD, on not waiting for fall to get boosted
2022 Nobel Peace Prize nominee Peter Hotez, MD, PhD, discusses his coronavirus vaccine, CorbeVax, as well as his Paxlovid rebound infection experience, and growing concerns around monkeypox. American Medical Association CXO Todd Unger hosts. Dr. Peter Hotez is dean of the National School of Tropical Medicine at Baylor College of Medicine, and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston.
August 4, 202217m 33s
Audio is streamed directly from the publisher (pdst.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
2022 Nobel Peace Prize nominee Peter Hotez, MD, PhD, discusses his coronavirus vaccine, CorbeVax, as well as his Paxlovid rebound infection experience, and growing concerns around monkeypox. American Medical Association CXO Todd Unger hosts.
Dr. Peter Hotez is dean of the National School of Tropical Medicine at Baylor College of Medicine, and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston.
Topics
mdpeter hotezcorbevaxpaxlovidhotezcoronavirustexas childrens hospitalcovid-19 vaccinescovis-19monkeypoxvaccinesnational school of tropical medicine at baylor college of medicinedean of national school of tropical medicine at baylor college of medicineboosterbaylor collegevax